895 pharmaceutical and medication recalls tracked. Stay informed about FDA drug safety alerts, prescription medications, over-the-counter drugs, and dietary supplements.
Looking for a specific drug? Use the search page to find recalls by medication name, manufacturer, or NDC number.
Dr. Reddy's Laboratories recalled 571 vials of Succinylcholine Chloride Injection on September 26, 2025. The recall stems from out-of-specification results during stability testing, indicating a decreased preservative concentration. The product is used for intravenous or intramuscular administration and is available by prescription only.
Synthes (USA) Products LLC recalled 120 units of medical screws on September 26, 2025. The screws were incorrectly labeled, posing a risk to patients. The recall affects multiple states and Canada.
Synthes (USA) Products LLC recalled 122 surgical screws on September 26, 2025. Mislabeling of screw lengths poses a serious risk to patients. Affected products include those used in the RFN-ADVANCED and Tibial Nail Advanced Systems.
Mad Rabbit recalled its "RELIEVE" numbing cream on September 25, 2025. This recall affects the product due to non-compliance with child-resistant packaging requirements. The cream poses a risk of serious injury or death from poisoning if ingested by young children.
Aloe Up recalled 11,386 tubes of Sport Performance Sunscreen Lotion SPF 30 on September 25, 2025. The recall follows cGMP deviations resulting in failed microbial count testing. Consumers should stop using the product immediately and seek guidance from healthcare providers.
DJO recalled 1,594 cold compression wraps on September 25, 2025. The wraps may leak or break when heated in the microwave, posing a burn risk. The recall affects models REF: DP163CT03-BLK-L, XL, and DP163CT02.
LeMaitre Vascular recalled one unit of its Collagen Vascular Graft on September 25, 2025. The device was packed in the wrong size labeled outer packaging, posing a high hazard to patients. Health providers and patients should stop using this device immediately and follow the recall instructions.
Zydus Pharmaceuticals recalled 600 bottles of Entecavir Tablets on September 24, 2025. The recall follows a failed impurity specification that poses health risks. Consumers should stop using the product immediately and contact healthcare providers for guidance.
Zydus Pharmaceuticals recalled 912 bottles of Entecavir Tablets on September 24, 2025, due to failed impurity specifications. The recall affects 30-count bottles of 0.5 mg tablets Distributed nationwide in the USA.
Biomet recalled 98 units of its ZipTight Acute AC Joint Implant on September 23, 2025. The recall follows reports of a potential missing slotted button assembly in one lot. Patients and healthcare providers must stop using the device immediately.
Becton Dickinson & Co. recalled 4,283 BD Phoenix M50 Instruments on September 23, 2025. Unauthorized access to service credentials raises risks to data confidentiality and integrity. The recall affects devices distributed worldwide, including the U.S., Canada, and several countries across Europe and Asia.
Becton Dickinson & Co. recalled 2,050 units of its EpiCenter Microbiology Data Management System on September 23, 2025. Unauthorized access to product service credentials may compromise patient data. The recall affects models distributed worldwide, including the U.S. and Puerto Rico.
Becton Dickinson recalled 62 units of its BD MAX System on September 23, 2025. Unauthorized access to product service credentials poses a high risk to data confidentiality and system integrity. The recall affects worldwide distribution, including the U.S., and requires immediate action from users.
Becton Dickinson & Co. recalled 38 units of BD Veritor Connect Software on September 23, 2025. Unauthorized access to product service credentials may compromise data confidentiality and integrity. Users must stop using the software immediately and follow recall instructions.
Becton Dickinson & Co. recalled 1,086 units of its BACTEC Blood Culture System on September 23, 2025. Unauthorized access to product service credentials poses a risk to data security. Affected systems include the BACTEC 9120 with catalog numbers 445570 and 445702.
Becton Dickinson & Co. recalled 177 units of the BD BACTEC Blood Culture System on September 23, 2025. Unauthorized access to product service credentials poses a high risk to patient data and device integrity. Healthcare providers must stop using the devices immediately and follow recall instructions.
RC Outsourcing LLC recalled 2,669 syringes of Bevacizumab on September 22, 2025. The recall stems from a lack of assurance of sterility, raising significant health risks. Healthcare providers and consumers should stop using the product immediately.
Alkem Laboratories recalled Atorvastatin Calcium Tablets, 40 mg, on September 19, 2025. The recall affects 90-count, 500-count, and 1000-count bottles due to failed dissolution specifications. Healthcare providers and consumers must stop using the product immediately.
Ascend Laboratories recalled atorvastatin calcium tablets on September 19, 2025, due to failed dissolution specifications. The recall affects 90-count, 500-count, and 1000-count bottles. Consumers should stop using these medications immediately.
Beckman Coulter recalled 160 DxC 500i Clinical Analyzer modules on September 19, 2025. A software anomaly may cause incorrect manual dilution factors, leading to false patient results. Healthcare providers must stop using the devices immediately to avoid erroneous diagnoses.
Ascend Laboratories recalled 141,984 bottles of Atorvastatin Calcium Tablets on September 19, 2025. The recall follows a failure to meet dissolution specifications. Consumers should stop using the product immediately and consult healthcare providers.
ARVIS recalled 21 units of its Shoulder Surgical Navigation Software on September 19, 2025. A complaint identified issues that may cause implant malalignment and decreased range of motion. Healthcare providers and patients must stop using the software immediately.
Beckman Coulter recalled 571 DxI 9000 Access Immunoassay Analyzers on September 19, 2025, due to a software anomaly. The defect may lead to inaccurate patient test results affecting diagnoses. Healthcare providers must stop using the device immediately and follow recall instructions.
Ascend Laboratories recalled Atorvastatin Calcium Tablets, 80 mg, on September 19, 2025. The recall affects 90-count and 500-count bottles due to failed dissolution specifications. Consumers should stop using the product immediately and consult their healthcare provider.
Receive immediate notifications when medications you care about are recalled. Stay safe with timely FDA drug safety alerts.